Taysha IPO Presentation Deck slide image

Taysha IPO Presentation Deck

Novel bicistronic vector design allows consistent expression of HEXA and HEXB genes HEXA and HEXB genes are required to produce the subunits of the beta-hexosaminidase A enzyme The novel bicistronic vector design enables 1:1 expression of HEXA and HEXB transgenes under the control of a single promoter with a P2A-self- cleaving linker - SD mice received vehicle or varying doses of TSHA-101 after 6 weeks: High dose (2.5x10¹1¹ vg/mouse) Medium dose (1.25x10¹¹ vg/mouse) Low dose (0.625x10¹1 vg/mouse) - Vehicle controls SSAAV ITR F. CAG Drive high levels of gene expression Full copies of hHEXB and hHEXA genes separated by P2A self-cleaving linker hHEXB P2A AAV9 capsid Brain tropism & favorable safety profile * hHEXA SSAAV ITR 18
View entire presentation